학술논문
PCN68 US AND CANADIAN COST-EFFECTIVENESS ANALYSES OF US ONCOLOGY TRIAL 9735 PROVIDE ADDITIONAL RATIONALE FOR AVOIDING ANTHRACYCLINES IN THE ADJUVANT TREATMENT OF OPERABLE BREAST CANCER
Document Type
Abstract
Author
Source
In Value in Health 2009 12(7):A269-A269
Subject
Language
ISSN
1098-3015